Acebutolol Prices

Acebutolol Prices December 2023

In the fourth quarter of 2023, the price of acebutolol in the United States reached 95331 USD/MT by December. Similarly, in China, the acebutolol prices hit 93585 USD/MT in the same month. Germany also saw acebutolol prices reaching 100265 USD/MT during Q4 2023.

Acebutolol Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Acebutolol Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of acebutolol pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of acebutolol at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of acebutolol price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing acebutolol price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Acebutolol Market Analysis

The global acebutolol market size reached US$ 328.75 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 514.4 Million, at a projected CAGR of 5.10% during 2023-2032.

• The rising prevalence of cardiovascular diseases (CVDs), like arrhythmias and hypertension, majorly among the aging population, is boosting the demand for acebutolol, which is a beta-blocker that can effectively manage hypertension. As per the reports of WHO, CVDs are considered the dominant cause of death globally. Approximately 17.9 million deaths are recorded annually due to CVDs. Moreover, the chances of heart ailments increase as the person grow older. According to the United Nations, demographic segment aged 65 years or above is increasing more rapidly than any other age groups. This observation suggests that by the year 2050, the global population aged 65 and above will increase from 10% in 2022 to 16%. This demographic shift will substantially aid in the market propulsion of cardiovascular drugs, including acebutolol.
• Acebutolol’s distinctive pharmacological characteristics, including intrinsic sympathomimetic activity and cardioselectivity, make it a preferable drug for patients with synchronous respiratory ailments. According to a research article published in the journal Pharmacotherapy, acebutolol provides an effective control of hypertension and causes fewer neurologic side effects while being as effective as other beta-blocking drugs. It can also be used in patients diagnosed with bronchospastic disease. Additionally, this drug has minimal metabolic effects and prevents elevation of blood lipid levels during long-term therapy. These advantageous properties make acebutolol preferable for a broader patient base, thereby boosting the product sales.  
• The market for acebutolol is also heavily benefitted by the increasing healthcare expenditure that facilitates the better access to treatment and medications options. According to the Institute for Health Metrics and Evaluation, 78% of the global expenditure on healthcare is observed in high-income countries, while 62% of the total global health expenditure is done by governments in different economies. According to the Centers for Medicare and Medicaid Services, the U.S. government spends 17.3% of its total GDP on the healthcare sector. This progressively increasing expenditure will expand the market for acebutolol.
• The rising adoption of the generic medicines has compelled the pharmaceutical sector to provide generic version of acebutolol. This has aided in increasing the cost-effectiveness of the drug, expanding its reach in developed as well as emerging economies.  According to industry reports, global generic drug market is expected to grow with a CAGR of 5.3% from 2024 to 2033, reaching USD 779.68 billion by 2033.
• Another significant driver of acebutolol market is extensive screening programs and magnified awareness of cardiovascular related issues that lead to early diagnosis and treatment of CVDs. This prescient approach amplifies the adoption of medications, including acebutolol, for managing cardiovascular ailments efficiently.

Acebutolol News

The report covers the latest developments, updates, and trends impacting the global acebutolol market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in acebutolol production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the acebutolol price trend.

Latest developments in the acebutolol industry:

• In June 2024, ANI Pharmaceuticals, one of the producers of acebutolol capsules, announced the acquisition Alimera Sciences Inc. The transaction has been approved by the Boards of Directors of both Alimera and ANI Pharmaceuticals, with Alimera valuing approximately $381 million in the initial payment. The transaction is expected to close late in the third quarter of 2024.
• In April 2024, Apotex, a manufacturer of acebutolol and other generic drugs, announced the acquisition of Searchlight Pharma, which is expected to be completed by mid-year. The acquisition will allow Apotex expansion with the addition of more than 60 Searchlight's products.

Product Description

Acebutolol, a beta-adrenergic drug, is generally used in management of ventricular arrhythmias and hypertension. It is antagonist and cardio selective, and exhibits exceptional pharmacological attributes, such as stabilizing effects on membranes and mild activity of intrinsic sympathomimetic. These characteristics aid in controlling blood pressure and heart rate. Acebutolol is a type of drug that depicts efficient absorption by the gastrointestinal tract. Post-absorption, this drug undergoes presystemic metabolism, resulting in the formation of an active molecule called diacetolol. This active molecule has the capability of improving the therapeutic effects of acebutolol. Furthermore, the cardioselectivity of acebutolol makes it an excellent drug for patients who suffer with respiratory complications, because it has a comparatively lower risk of bronchoconstriction than a nonselective beta-blocker.

Several pharmaceutical companies manufacture acebutolol under various brand names, such as Apo-Acebutolol and Sectral. These are available in different oral dosages and are highly renowned for maintaining steady cardiac function during physical activities and lowering ventricular ectopic beats. The drug’s advantageous profile, associated with pharmacokinetics, coupled with its well-documented efficacy and safety, highlights its importance in cardiovascular therapeutics. 

Regional Coverage

The report provides a detailed analysis of the acebutolol market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the acebutolol price trend. 

Global Acebutolol Price

The report offers a holistic view of the global acebutolol pricing trends in the form of acebutolol price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of acebutolol but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed acebutolol demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Acebutolol Price

European acebutolol prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed acebutolol price information for a comprehensive list of countries.

North America Acebutolol Price

The analysis of acebutolol prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific acebutolol historical data within the United States and Canada can also be provided.

Middle East and Africa Acebutolol Price

The report explores the acebutolol pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on acebutolol prices for countries can also be provided.

Asia Pacific Acebutolol Price

The acebutolol pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This acebutolol price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Acebutolol Price

The analysis of acebutolol prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of acebutolol pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting acebutolol price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The acebutolol price charts ensure our clients remain at the forefront of the industry.